Historical Background John Fothergill 1773 Charles Bell 1829 - - PowerPoint PPT Presentation

historical background
SMART_READER_LITE
LIVE PREVIEW

Historical Background John Fothergill 1773 Charles Bell 1829 - - PowerPoint PPT Presentation

Historical Background John Fothergill 1773 Charles Bell 1829 Walter Dandy 1934 Images from Prasad, et al. Criteria for Diagnosis Paroxsymal, usually unilateral attacks of facial pain in one or more trigeminal divisions


slide-1
SLIDE 1
slide-2
SLIDE 2

Historical Background

 John Fothergill – 1773  Charles Bell – 1829  Walter Dandy –1934

Images from Prasad, et al.

slide-3
SLIDE 3

Criteria for Diagnosis

 Paroxsymal, usually unilateral attacks of facial pain in one

  • r more trigeminal divisions lasting <1 sec – 2 min

 At least one of the following: 1) Intense, sharp, superficial

  • r stabbing quality, 2) Precipitation by “triggers” 3) Relative

absence of symptoms between attacks  Stereotyped patterns of attacks within individual patients  No objective neurologic deficit  No other identified causes for facial pain

The International Classification of Headache Disorders, 2nd Ed.

slide-4
SLIDE 4

Classification of Facial Pain

Burcheil, KJ. “A New Classification for Facial Pain.” Neurosurgery. 2003

slide-5
SLIDE 5

Treatment Options

 Medication  Percutaneous Rhizotomy (Glycerol, Balloon, or RFA)  Stereotactic Radiosurgery (1951)  Microvascular Decompression

slide-6
SLIDE 6
slide-7
SLIDE 7

Gamma knife for Tic

 Safe and effective  Non-invasive  Drawbacks: Durability and trigeminal dysfunction

slide-8
SLIDE 8

MCG Patient Demographics

 318 Patients treated, Mean follow up 16.25 months (3-120 mo)  33.6% Male/66.4% Female  81.4% Caucasian/15.1% African American  No Prior – 76.7%  MVD – 4.4%  GKRS – 0.6%  Other – 18.2%

slide-9
SLIDE 9

Pain Characteristics

 289 (90.9%) with TN1 or TN2  51.8% Right/47.1% Left/1.1% Bilateral

slide-10
SLIDE 10

Treatment Protocol

 80.7 Gy mean maximum dose to nerve (70-90Gy)  Single Shot (96.8%)  4mm collimator (100%)  82.7% Model B

slide-11
SLIDE 11

Response to Gamma

 Trigeminal Neuralgia Type 1 and Type 2  91.2% with good/excellent outcomes (Class I-III)  60.3% with pain-free outcomes  8.8% with little/no response to treatment (Class IV-V)

PFOM 36.3% PFWM 24% PWM 30.9% NR (IV/V) 8.8%

slide-12
SLIDE 12

Neuropathy, MS, and Repeat GKRS

Good/Excelle nt No Response Pain-Free n Neuralgia 91.2% 8.8% 60.3% 204 Neuropathy 57.1% 42.9% 21.4% 14 MS 77.8% 22.2% 66.7% 9 Repeat GKRS 91.7% 8.3% 37.5% 24

slide-13
SLIDE 13

Subgroup Comparison

Good/Excellent Pain Freedom p-value p-value Neuralgia vs Neuropathy <0.001 <0.005 Neuralgia vs MS NS NS Neuralgia vs Repeat GKRS NS <0.05 Age <65 vs >65 NS <0.01 Smoking NS NS

 The neuropathy group was less likely to experience a Good/Excellent outcome, or experience a pain-free outcome than the neuralgia group  The Repeat GKRS group was less likely to achieve a pain free outcome, but not less likely to respond to therapy than patients undergoing initial treatment  Patients older than 65 were more likely to experience a pain free response than patients less than 65

slide-14
SLIDE 14

Retreatment Response

 Retreatment mean max dose 69.8 Gy  The retreatment group was less likely to achieve a pain free response than the initial treatment group on second treatment (p < 0.05)

Good/Exc ellent Pain-Free No Response n Neuralgia 91.2 60.3 8.8 204 First Tx 94 48 6 50 Second Tx 91.7 37.5 8.3 24

slide-15
SLIDE 15

Conclusions

 Gamma knife radiosurgery is an effective option for the treatment of medically refractory trigeminal neuralgia  Durability is likely the greatest weakness of this treatment modality  Useful for patients with MS as well as Neuropathy, although efficacy may be decreased in these settings  Repeat GKRS is possible after initial treatment failure, but a pain free response may be less likely

slide-16
SLIDE 16

Thank you

 Special thanks to Christina Hamilton and Dr. Vender  Thank you for your attention